Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Chronic kidney disease - determinants of progression and cardiovascular risk. PROGREDIR cohort study: design and methods

Full text
Author(s):
Muniz Domingos, Maria Alice ; Goulart, Alessandra Carvalho ; Lotufo, Paulo Andrade ; Martins Bensenor, Isabela Judith ; de Oliveira Titan, Silvia Maria
Total Authors: 5
Document type: Journal article
Source: São Paulo Medical Journal; v. 135, n. 2, p. 133-139, MAR-APR 2017.
Web of Science Citations: 6
Abstract

CONTEXT AND OBJECTIVE: Chronic kidney disease (CKD) has become an important public health issue. The socioeconomic burden of renal replacement therapy (RRT) is very high, as is CKD-related cardiovascular mortality and morbidity. Preventive and therapeutic measures only have modest impact and more research is needed. Few cohort studies have been conducted on populations with CKD. Our aim was to establish a cohort that would include more advanced forms of CKD (stages 3 and 4). Data collection was focused on renal and cardiovascular parameters. DESIGN AND SETTING: Prospective cohort study; Sao Paulo, Brazil. METHODS: Recruitment took place in Hospital das Clinicas, Sao Paulo, from March 2012 to December 2013. Data relating to medical history, food-frequency questionnaire, anthropometry, laboratory work-up, calcium score, echocardiography, carotid intimal-medial thickness, pulse-wave velocity, retinography and heart rate variability were collected. A biobank including serum, plasma, post-oral glucose tolerance test serum and plasma, urine (morning and 24-hour urine) and DNA was established. RESULTS: 454 participants (60% men and 50% diabetics) of mean age 68 years were enrolled. Their mean estimated glomerular filtration rate-CKD Epidemiology Collaboration was 38 ml/min/1.73m(2). Follow-up is ongoing and the main outcomes are the start of RRT, cardiovascular events and death. CONCLUSIONS: The PROGREDIR cohort is a promising prospective study that will allow better understanding of CKD determinants and validation of candidate biomarkers for the risks of CKD progression and mortality. (AU)

FAPESP's process: 11/17341-0 - Chronic kidney disease: determinants of progression and cardiovascular risk: a cohort study in a brazilian population
Grantee:Silvia Maria de Oliveira Titan
Support Opportunities: Regular Research Grants